Macrogenics' IPO

Macrogenics raised a round of funding on October 10, 2013. Investors include Public.

MacroGenics is a biotechnology company focused on the discovery, development and delivery to patients of biologics for treatment of cancer, autoimmune disorders and infectious diseases. MacroGenics ha…

Articles about Macrogenics' IPO: